As the coronavirus outbreak continues to spread around the world, only a couple of companies have successfully brought treatments to clinical trials so far. One of them is Gilead Sciences (NASDAQ: GILD), whose former Ebola drug candidate, remdesivir, appears to be an effective way to treat COVID-19 symptoms.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,